Global CV Risk Management: Is it Practical?

Presented By:		JoAnne M. Foody, MD, FACC, FAHA Staff Physician Director, Cardiovascular Wellness Center Brigham and Women’s Hospital Boston, Massachusetts

Program Description:	This CME activity consists of an educational component (ie, slides, audio lecture, newsletter) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is 30 minutes.
General Information:	Requirements for Successful Completion: This CME activity consists of an educational component (ie, slides, audio lecture, newsletter) in an electronic format, which is followed by an online post-test. There is no fee to participate in this CME activity or to receive CME credit. Certificates are awarded upon successful completion (80% proficiency) of the post-test. In order to receive credit, participants must view the presentaion in its entirety. Media: Internet Release Date:    March 3, 2008 Expiration Date:  March 2, 2010
Target Audience:	Cardiologists, Endocrinologists, and internists with an interest in CV disease
Program Overview:	Hypertension is the chief risk factor for cardiovascular (CV) and end-stage renal disease, and currently affects a staggering 72 million individuals in the US. When blood pressure (BP) is well controlled, the clinical benefit can be enormous; however, control remains a challenge. Hypertension is rarely uncomplicated and often clusters with dyslipidemia and diabetes, thereby vastly increasing the potential for major CV events. Understanding when and how to use multiple drug classes can be complex, particularly when patients present with complicated comorbidities. Since not all patients look or present identically, further understanding of drug interactions by ethnicity or gender is essential. Clinicians need to become more aware that all agents within a given drug class are not the same, and that even minor structural variations among drugs may result in potentially significant pharmacokinetic and clinical effects. Treatment regimens that incorporate multiple drug classes and that are tailored to patient needs have proved the most effective as well as the best tolerated, thereby promoting patient adherence and the likelihood of meeting critical goals over the long term. This CME program is designed to increase awareness on the necessity of global risk reduction and ways to enhance patient adherence.
Learning Objectives:	• Understand how global risk factor management, aggressive medical treatment, and lifestyle modification can decrease the prevalence of CV disease • Apply strategies to reduce medication non compliance and promote quality of life • Enhance patient adherence via partnership and mutual decision making to prevent CV morbidity
Faculty Disclosure:	The University of Florida College of Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they simply are noted here to fully inform participants. JoAnne M. Foody, MD, has indicated that she has a financial arrangement or affiliation with Merck & Co Inc, Pfizer Inc, and sanofi-aventis. The types of affiliation/financial interest are consultant agreements.
Continuing Medical Education Credit:
	Accreditation
	The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
	Credit
	The University of Florida College of Medicine designates this educational activity for a maximum of .50 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
	This continuing education activity was planned in accordance with the ACCME essentials and reviewed by Carl J. Pepine, MD, Program Chair.
	Click here for disclosure and disclaimer information
Commercial Support:	This CME activity is supported by an educational grant from Boehringer Ingelheim .
System Requirements:	In order to view the presentation, your computer must have a media player such as Windows Media Player, Quicktime, or RealOne.
CME Contact:	For any question regarding this Internet CME activity, please contact the Office of Continuing Medical Education at 352-265-8081.
	The University of Florida College of Medicine has received permission to use this copyrighted material within a CME activity on the internet.

Take this presentation with you:
Download this Online Lecture as an MP3 and load it onto your iPod or other portable audio player.
MP3 Audio File
(Right-click and select "Save Target As..." to download)